AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | Special Assistant, Rep. Joe Schwarz, 2005-2006 |
| SHELAGH FOSTER | — |
Health Issues HCR
H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | Special Assistant, Rep. Joe Schwarz, 2005-2006 |
| SHELAGH FOSTER | — |
Medicare/Medicaid MMM
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors SGR Repeal, advocacy for the repeal and temporary SGR extensions (H.R. 4213, a bill to extend certain tax policies and stimulate job growth; H.R. 4581, the Continuing Extensions Act of 2010; and H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010.)
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT BLACKWELL | Special Assistant, Rep. Joe Schwarz, 2005-2006 |
| SHELAGH FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.